Mereo BioPharma Group plc MREO

Latest FY: 2025 Healthcare Biotechnology
Market Price $0.27
Market Cap $215.49M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025)
$500.00K
Full year reported
Net Income ↑3.2% YoY
-$41.88M
Net Margin: -8,375.6%
Free Cash Flow ↑7.6% YoY
-$30.99M
FCF Yield: -14.38%
EPS (Diluted) ↑16.7% YoY
$-0.05
Basic: $-0.05
Return on Equity Efficiency
-102.4%
ROA: -91.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MREO)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2024: Revenue YoY (-100.0%) is identical to Gross Profit YoY (-100.0%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $-38.8M $-0.56 $-32.1M $-32.2M
FY 2018 $-32.0M +17.4% $-0.45 +19.6% $-23.1M $-23.2M +27.9%
FY 2019 $-34.8M -8.8% $-0.39 +13.3% 0.00% $-45.9M $-46.0M -98.3%
FY 2020 $-163.6M -369.6% $-0.48 -23.1% 0.00% $-28.3M $-28.4M +38.3%
FY 2021 $36.5M $18.6M $12.7M +107.8% $-0.05 +89.6% 0.00% $-5.2M $-5.8M +79.6%
FY 2022 -100.0% $35.5M $-34.2M -368.7% $-0.06 -20.0% 0.00% $-38.8M $-38.8M -572.5%
FY 2023 $10.0M $5.1M $-29.5M +13.8% $-0.04 +33.3% 0.00% $-21.1M $-21.1M +45.6%
FY 2024 -100.0% $-43.3M -46.8% $-0.06 -50.0% 0.00% $-32.8M $-33.5M -58.7%
FY 2025 $0.5M $0.2M $-41.9M +3.2% $-0.05 +16.7% 0.00% $-31.0M $-31.0M +7.6%
$

Valuation

Market Price $0.27
Market Cap $215.49M
Enterprise Value $174.70M
P/E Ratio N/A
P/B Ratio 5.31
FCF Yield -14.38%
Dividend Yield 0.00%
Shares Outstanding 798,093,044
%

Profitability & Margins

Gross Margin 49.00%
Operating Margin -8,021.40%
Net Margin -8,375.60%
Return on Equity (ROE) -102.35%
Return on Assets (ROA) -91.20%
Asset Turnover 0.01x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 10.46
Cash Ratio 9.53
Debt / Equity 0.005
Debt / Assets 0.004
Cash & Equivalents $40.99M
Total Debt $202.00K
Book Value / Share $0.05
💧

Cash Flow Efficiency

Operating Cash Flow -$30.97M
Capital Expenditures (CapEx) $20.00K
Free Cash Flow -$30.99M
OCF / Revenue -6,194.20%
FCF / Revenue -6,198.20%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.05
EPS (Basic) $-0.05
Dividends / Share N/A
Book Value / Share $0.05
EPS YoY Growth 16.67%
🏛️

Balance Sheet (FY 2025)

Total Assets $45.92M
Total Liabilities $5.00M
Stockholders' Equity $40.92M
Current Assets $45.02M
Current Liabilities $4.30M